Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.16 USD | -0.92% | +1.89% | -35.14% |
13/05 | Truist Securities Trims Price Target on Coherus BioSciences to $7 From $8, Maintains Buy Rating | MT |
09/05 | Transcript : Coherus BioSciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.14% | 25Cr | |
+8.29% | 11TCr | |
+10.21% | 10TCr | |
+0.41% | 2.23TCr | |
-11.90% | 2.24TCr | |
-5.99% | 1.91TCr | |
-37.36% | 1.8TCr | |
-5.17% | 1.79TCr | |
+7.70% | 1.43TCr | |
+37.65% | 1.25TCr |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- Maxim Downgrades Coherus BioSciences to Hold From Buy